Results 191 to 200 of about 2,223,573 (201)

Capilliposide from Lysimachia capillipes inhibits AKT activation and restores gefitinib sensitivity in human non-small cell lung cancer cells with acquired gefitinib resistance

Acta Pharmacologica Sinica, 2016
Bing Xia, Er Jin, Sheng-Lin Ma
exaly  

Linc01014 regulates gefitinib resistance in oesophagus cancer via EGFR-PI3K-AKT-mTOR signalling pathway

Journal of Cellular and Molecular Medicine, 2020
Song Zhao, Song Zhao, Guanghui Cui
exaly  

METHOD FOR TREATING GEFITINIB RESISTANT CANCER

2006
HABER DANIEL, BELL DAPHNE WINIFRED, SETTLEMAN JEFFREY E, SORDELLA RAFFAELLA, GODIN-HEYMANN NADIA G, KWAK EUNICE L, RABINDRAN SRIDHAR KRISHNA   +6 more
openaire   +7 more sources

Mathematical analysis of gefitinib resistance of lung adenocarcinoma caused by amplification

Biochemical and Biophysical Research Communications, 2019
Yoshinori Murakami, Kenji Tamura, Shuji Kawasaki   +2 more
exaly  

miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124

Biochemical and Biophysical Research Communications, 2014
Yu Deng, Yi Gao, Wei Ping
exaly  

Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA)

British Journal of Cancer, 2005
R Noro, S Kudoh, A Gemma
exaly  

BCRP/ABCG2 levels account for the resistance to topoisomerase I inhibitors and reversal effects by gefitinib in non-small cell lung cancer

Cancer Chemotherapy and Pharmacology, 2006
Hiroshi Soda, Ken Shiozawa, Hikaru Yabuuchi   +2 more
exaly  

The PI3K/AKT pathway promotes gefitinib resistance in mutant

International Journal of Cancer, 2014
Victor Jeannot, Benoît Busser, Elisabeth Brambilla, Marie Wislez, Blaise Robin, Jacques Cadranel, Jean-Luc Coll, Amandine Hurbin   +7 more
openaire   +1 more source

MiR-181a contributes gefitinib resistance in non-small cell lung cancer cells by targeting GAS7

Biochemical and Biophysical Research Communications, 2018
Yu Deng, Yi Gao, Wei Ping
exaly  

MiR-130a Overcomes Gefitinib Resistance by Targeting Met in Non-Small Cell Lung Cancer Cell Lines

Asian Pacific Journal of Cancer Prevention, 2014
exaly